Clinical trial
The Role of Kynurenine Pathway Metabolites in Perinatal Depression and Suicidality
NCT02566980 is registered in ClinicalTrials.gov with Michigan State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Kynurenine Pathway Metabolites in Perinatal Depression and Suicidality
- Lead sponsor
- Michigan State University
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 23, 2014
- Completion date
- February 28, 2017
- Enrollment
- 209 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
depression and suicide, mood disorders, other perinatal conditions